Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Shortage reports
Actual shortage:
214 (7%)
Anticipated shortage:
0 (0%)
Avoided shortage:
10 (0%)
Resolved:
2706 (92%)
2930
Discontinuation Reports
To be discontinued:
2 (1%)
Discontinued:
298 (99%)
Reversed:
0 (0%)
300
363 (11%)
99 (46%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-TERBINAFINE | 250MG | TABLET | Actual shortage | 2017-03-13 | 2020-02-13 | 1655 |
| TEVA-TERIPARATIDE INJECTION | 250MCG | SOLUTION | Resolved | 2022-10-28 | 2022-12-15 | 173004 |
| TEVA-TIAPROFENIC ACID | 300MG | TABLET | Resolved | 2020-01-24 | 2020-02-13 | 104350 |
| TEVA-TIAPROFENIC ACID | 200MG | TABLET | Resolved | 2021-11-18 | 2022-02-17 | 149612 |
| TEVA-TIAPROFENIC ACID | 200MG | TABLET | Resolved | 2023-07-20 | 2023-10-05 | 199360 |
| TEVA-TOBRAMYCIN | 60MG | SOLUTION | Resolved | 2022-07-25 | 2022-12-08 | 165447 |
| TEVA-TOBRAMYCIN | 60MG | SOLUTION | Resolved | 2023-06-08 | 2023-06-21 | 194160 |
| TEVA-TOBRAMYCIN | 60MG | SOLUTION | Actual shortage | 2024-05-09 | 2025-04-24 | 227495 |
| TEVA-TOBRAMYCIN | 60MG | SOLUTION | Resolved | 2020-02-21 | 2020-03-26 | 106942 |
| TEVA-TOBRAMYCIN | 60MG | SOLUTION | Resolved | 2021-10-14 | 2021-12-17 | 147231 |
| TEVA-TOBRAMYCIN | 60MG | SOLUTION | Resolved | 2020-01-17 | 2020-02-07 | 103593 |
| TEVA-TOBRAMYCIN | 60MG | SOLUTION | Resolved | 2017-05-23 | 2018-07-30 | 10911 |
| TEVA-TOLTERODINE | 1MG | TABLET | Resolved | 2024-03-21 | 2024-03-21 | 222947 |
| TEVA-TOLTERODINE | 1MG | TABLET | Actual shortage | 2023-10-05 | 2024-01-08 | 206410 |
| TEVA-TOLTERODINE | 2MG | TABLET | Actual shortage | 2023-10-05 | 2024-01-08 | 206413 |
| TEVA-TOLTERODINE | 1MG | TABLET | Resolved | 2019-08-22 | 2021-08-05 | 92218 |
| TEVA-TOLTERODINE | 1MG | TABLET | Resolved | 2019-09-05 | 2021-07-22 | 93152 |
| TEVA-TOLTERODINE LA | 4MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2020-01-30 | 2020-03-19 | 104902 |
| TEVA-TOLTERODINE LA | 2MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2021-03-18 | 2021-04-29 | 135952 |
| TEVA-TOLTERODINE LA | 4MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2023-04-27 | 2023-06-27 | 190713 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-METOPROLOL | 50MG | TABLET | Discontinued | 2020-07-10 | 2020-07-10 | 119976 |
| TEVA-MIRTAZAPINE | 30MG | TABLET | Discontinued | 2025-03-20 | 2025-03-20 | 253165 |
| TEVA-MIRTAZAPINE | 30MG | TABLET | Discontinued | 2024-10-11 | 2024-10-11 | 240081 |
| TEVA-MIRTAZAPINE | 30MG | TABLET | Discontinued | 2021-02-12 | 2021-02-12 | 133908 |
| TEVA-NAPROXEN | 250MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14055 |
| TEVA-NAPROXEN SODIUM DS | 550MG | TABLET | Discontinued | 2019-04-11 | 2019-04-11 | 81350 |
| TEVA-NORFLOXACIN | 400MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65013 |
| TEVA-NYSTATIN | 100000UNIT | SUSPENSION | Discontinued | 2018-10-12 | 2018-10-12 | 63946 |
| TEVA-NYSTATIN | 100000UNIT | SUSPENSION | Discontinued | 2018-10-12 | 2018-10-12 | 63949 |
| TEVA-NYSTATIN | 100000UNIT | CREAM | Discontinued | 2020-07-10 | 2020-07-10 | 120056 |
| TEVA-OXYBUTYNIN | 5MG | TABLET | Discontinued | 2024-06-28 | 2024-06-29 | 231586 |
| TEVA-OXYBUTYNIN | 5MG | TABLET | Discontinued | 2024-10-11 | 2024-10-11 | 240078 |
| TEVA-PANTOPRAZOLE MAGNESIUM | 40MG | TABLET (DELAYED-RELEASE) | Discontinued | 2021-02-12 | 2021-02-12 | 133891 |
| TEVA-PAROXETINE | 10MG | TABLET | Discontinued | 2025-03-20 | 2025-03-20 | 253182 |
| TEVA-PAROXETINE | 10MG | TABLET | Discontinued | 2019-04-11 | 2019-04-11 | 81313 |
| TEVA-PAROXETINE | 20MG | TABLET | Discontinued | 2025-03-20 | 2025-03-20 | 253160 |
| TEVA-PAROXETINE | 30MG | TABLET | Discontinued | 2019-12-09 | 2019-12-09 | 100540 |
| TEVA-PAROXETINE | 20MG | TABLET | Discontinued | 2019-12-09 | 2019-12-09 | 100547 |
| TEVA-PAROXETINE | 10MG | TABLET | Discontinued | 2020-02-21 | 2020-02-21 | 106898 |
| TEVA-PAROXETINE | 30MG | TABLET | Discontinued | 2020-02-21 | 2020-02-21 | 106901 |